Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Seeley

Showing results (401-410 of 448) with videos related to

Pageof 45
Sort By:
Nature|February 24, 2022
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13AX Rosa Ma, Mercedes Prudencio, Yuka Koike, et al.
The Lancet. Neurology|August 21, 2021
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyElisabeth H Thijssen, Renaud La Joie, Amelia Strom, et al.
Neurobiology of Aging|July 31, 2012
Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotypeNicola J Rutherford, Michael G Heckman, Mariely Dejesus-Hernandez, et al.
JAMA Neurology|July 19, 2016
Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network DegenerationKamalini G Ranasinghe, Katherine P Rankin, Peter S Pressman, et al.
Molecular Neurodegeneration|June 27, 2013
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's diseaseSruti Rayaprolu, Bianca Mullen, Matt Baker, et al.
Human Molecular Genetics|May 26, 2011
Ataxin-2 repeat-length variation and neurodegenerationOwen A Ross, Nicola J Rutherford, Matt Baker, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2018
Multisite study of the relationships between antemortem [<sup>11</sup>C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathologyRenaud La Joie, Nagehan Ayakta, William W Seeley, et al.
Neurobiology of Aging|May 29, 2014
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriersMarka van Blitterswijk, Bianca Mullen, Michael G Heckman, et al.
Neurology|December 24, 2010
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriersN Finch, M M Carrasquillo, M Baker, et al.
Brain : a Journal of Neurology|May 1, 2019
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group reportPeter T Nelson, Dennis W Dickson, John Q Trojanowski, et al.
Pageof 45

Showing results (401-410 of 448) with videos related to

Sort By:
Pageof 45
Nature|February 24, 2022
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13AX Rosa Ma, Mercedes Prudencio, Yuka Koike, et al.
The Lancet. Neurology|August 21, 2021
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyElisabeth H Thijssen, Renaud La Joie, Amelia Strom, et al.
Neurobiology of Aging|July 31, 2012
Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotypeNicola J Rutherford, Michael G Heckman, Mariely Dejesus-Hernandez, et al.
JAMA Neurology|July 19, 2016
Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network DegenerationKamalini G Ranasinghe, Katherine P Rankin, Peter S Pressman, et al.
Molecular Neurodegeneration|June 27, 2013
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's diseaseSruti Rayaprolu, Bianca Mullen, Matt Baker, et al.
Human Molecular Genetics|May 26, 2011
Ataxin-2 repeat-length variation and neurodegenerationOwen A Ross, Nicola J Rutherford, Matt Baker, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2018
Multisite study of the relationships between antemortem [<sup>11</sup>C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathologyRenaud La Joie, Nagehan Ayakta, William W Seeley, et al.
Neurobiology of Aging|May 29, 2014
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriersMarka van Blitterswijk, Bianca Mullen, Michael G Heckman, et al.
Neurology|December 24, 2010
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriersN Finch, M M Carrasquillo, M Baker, et al.
Brain : a Journal of Neurology|May 1, 2019
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group reportPeter T Nelson, Dennis W Dickson, John Q Trojanowski, et al.
Pageof 45